ATE513853T1 - Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten - Google Patents

Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten

Info

Publication number
ATE513853T1
ATE513853T1 AT07701338T AT07701338T ATE513853T1 AT E513853 T1 ATE513853 T1 AT E513853T1 AT 07701338 T AT07701338 T AT 07701338T AT 07701338 T AT07701338 T AT 07701338T AT E513853 T1 ATE513853 T1 AT E513853T1
Authority
AT
Austria
Prior art keywords
peg
denotes
residue
alkyl
peptides
Prior art date
Application number
AT07701338T
Other languages
English (en)
Inventor
Peter Petzelbauer
Rainer Henning
Sonja Reingruber
Original Assignee
Fibrex Medical Res & Dev Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrex Medical Res & Dev Gmbh filed Critical Fibrex Medical Res & Dev Gmbh
Application granted granted Critical
Publication of ATE513853T1 publication Critical patent/ATE513853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT07701338T 2006-02-23 2007-02-23 Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten ATE513853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT3012006 2006-02-23
PCT/AT2007/000095 WO2007095660A1 (en) 2006-02-23 2007-02-23 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
ATE513853T1 true ATE513853T1 (de) 2011-07-15

Family

ID=38042580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07701338T ATE513853T1 (de) 2006-02-23 2007-02-23 Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten

Country Status (15)

Country Link
US (3) US7799758B2 (de)
EP (2) EP2256131A1 (de)
JP (1) JP2009527502A (de)
KR (1) KR20090005300A (de)
CN (1) CN101389653A (de)
AT (1) ATE513853T1 (de)
AU (1) AU2007219031B2 (de)
CA (1) CA2641908A1 (de)
ES (1) ES2371038T3 (de)
IL (1) IL193435A0 (de)
MX (1) MX2008010930A (de)
NO (1) NO20084002L (de)
RU (1) RU2008137796A (de)
WO (1) WO2007095660A1 (de)
ZA (1) ZA200807028B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE439856T1 (de) * 2004-06-25 2009-09-15 Fibrex Medical Res & Dev Gmbh Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
WO2009038729A2 (en) * 2007-09-17 2009-03-26 Regenerx Biopharmaceuticals, Inc. Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
US20090286740A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
US20090286725A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
US7884074B2 (en) 2008-05-15 2011-02-08 Ikaria Development Subsidiary Two, LLC Compounds and methods for prevention and/or treatment of inflammation using the same
US8088890B2 (en) * 2008-09-26 2012-01-03 Fibrex Medical Research & Development Gmbh Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
WO2010043444A2 (en) * 2008-10-15 2010-04-22 Fibrex Medical Research & Development Gmbh Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof
US20100152832A1 (en) * 2008-12-12 2010-06-17 Medtronic Vascular, Inc. Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta
US8841257B2 (en) * 2009-04-10 2014-09-23 Board Of Regents, The University Of Texas System Inhibitors of STAT3 and uses thereof
WO2019011879A1 (en) 2017-07-09 2019-01-17 Rainer Henning THERAPEUTIC AGENT FOR THE TREATMENT OF CAPILLARY LEAK SYNDROME
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
EP3912679A1 (de) 2020-05-19 2021-11-24 Johann Wolfgang Goethe-Universität Frankfurt am Main Bbeta-15-42 zur behandlung von viraler endothelitis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
SG89295A1 (en) 1991-03-15 2002-06-18 Amgen Inc Pegylation of polypeptides
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6323311B1 (en) * 1999-09-22 2001-11-27 University Of Utah Research Foundation Synthesis of insulin derivatives
JP4181874B2 (ja) * 2000-12-12 2008-11-19 ファイブレックス メディカル リサーチ アンド デベロップメント ゲーエムベーハー ペプチドおよび／またはタンパク質、並びにその治療用および／または予防用医薬成分を調製するための使用
DE10314329A1 (de) * 2003-03-28 2004-10-21 Zf Friedrichshafen Ag Antriebsstrang zum Antrieb eines Mobil-Fahrzeugs
NZ544024A (en) 2003-05-12 2009-06-26 Affymax Inc Novel poly(ethylene glycol) modified compounds and uses thereof
ATE439856T1 (de) * 2004-06-25 2009-09-15 Fibrex Medical Res & Dev Gmbh Verwendung von peptiden, die aus der b beta kette des humanen fibrinogens abgeleitet wurden, zur behandlung von schock
AT502987A1 (de) * 2005-12-23 2007-07-15 Fibrex Medical Res & Dev Gmbh Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen

Also Published As

Publication number Publication date
CA2641908A1 (en) 2007-08-30
US20110098442A1 (en) 2011-04-28
AU2007219031B2 (en) 2011-11-03
MX2008010930A (es) 2008-10-29
EP1987062B1 (de) 2011-06-22
CN101389653A (zh) 2009-03-18
NO20084002L (no) 2008-11-18
US20100279924A1 (en) 2010-11-04
KR20090005300A (ko) 2009-01-13
AU2007219031A1 (en) 2007-08-30
JP2009527502A (ja) 2009-07-30
IL193435A0 (en) 2011-08-01
RU2008137796A (ru) 2010-03-27
US7799758B2 (en) 2010-09-21
EP1987062A1 (de) 2008-11-05
ES2371038T3 (es) 2011-12-26
US20080039388A1 (en) 2008-02-14
EP2256131A1 (de) 2010-12-01
WO2007095660A1 (en) 2007-08-30
ZA200807028B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
ATE513853T1 (de) Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten
BRPI0413276B8 (pt) derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
DE60314495D1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
DE602007009995D1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
ATE551422T1 (de) Aprotininpolypeptide zum transport einer verbindung durch die blut-hirn-schranke
RS52535B (en) PHARMACEUTICAL MIXTURES CONTAINING ACTIVIN-ACTRIIA ANTAGONISTS AND THEIR USE IN THE PREVENTION OR TREATMENT OF MULTIPLE MYELOMA
PE20090711A1 (es) Region constante de anticuerpo mutante
HK1161599A1 (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
AR061097A1 (es) Procedimiento para sintetizar timosinas
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
DE60305113T2 (de) Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
UA88481C2 (ru) Донепезила фумарат, пригодный для получения фармацевтических композиций
DE602007014210D1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
NO20076448L (no) Novel piperidine carboxylic acid amide derivatives
JP2009527503A5 (de)
EA201170889A1 (ru) Изделия на основе полимолочной кислоты и их использование
MX2010012042A (es) Peptidos, peptidomimeticos y derivados de los mismos, su fabricacion asi como su uso para preparar una composicion farmaceutica terapeutica y/o preventivamente activa.
NO20070665L (no) Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer
DE602005024554D1 (de) Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür
CY1113279T1 (el) Φαρμακευτικη συνθεση 271
NO20082127L (no) Antagonister mot interaksjon av PF4 og Rantes
DE602005023712D1 (de) Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1987062

Country of ref document: EP